Anuradha Roy, Ph.D.

Director, High Throughput Screening Lab
Primary office:
Shankel Structural Biology Center


Anuradha Roy is the director for the High Throughput Screening Laboratory.

Anu received her post-doctoral training at The Cleveland Clinic Foundation, and has more than 15 years of experience post-transcriptional gene regulation/drug discovery.  She has lead various aspects of drug discovery ranging from target identification and validation, primary and secondary assay development and optimization, high throughput screening campaigns and  hit to lead optimization at PTC Therapeutics Inc., New Jersey. Anu is on the Section Editor for News and Patents of the Journal Combinatorial Chemistry and High Throughput Screening.  

Dr. Roy received a Master of Science degree from the Jawaharlal Nehru University, India, in Life Sciences in 1986.  She obtained her Ph.D. in molecular biology/biochemistry from the Jawaharlal Nehru University in 1991.


Biochemistry & Protein Science

Bioinformatics & Modeling


Materials Characterization

Molecular Structures

Translational Biology

Ability to set up 24 NMR experiments at one time and eliminate periodic user intervention
Screen up to 100,000 compounds in two days for endpoint assays
Next-generation genome sequencing
Near-infrared and bioluminescence imaging instrumentation to track gene of interest and/or tumor growth
Expertise in the design and stability of various pharmaceutical dosage forms
More than 40 computational chemistry software programs and databases
KU Today